Skip to main content

Ackman, Valeant Pharmaceuticals announce $290 million settlement with Allergan

The agreement marks a change from previous terms that required Valeant to pay 60 percent in the settlement.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.